Get the Stockscreener App
11.50
4.64%
0.51
After Hours:
11.53
0.03
+0.26%
Contineum Therapeutics Inc stock is traded at $11.50, with a volume of 121.17K.
It is up +4.64% in the last 24 hours and up +91.67% over the past month.
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
See More
Previous Close:
$10.99
Open:
$11.05
24h Volume:
121.17K
Relative Volume:
0.48
Market Cap:
$248.69M
Revenue:
-
Net Income/Loss:
$-35.46M
P/E Ratio:
-27.26
EPS:
-0.4218
Net Cash Flow:
$-34.00M
1W Performance:
+10.05%
1M Performance:
+91.67%
6M Performance:
+88.52%
1Y Performance:
-35.17%
1-Day Range:
$10.74
$11.59
1-Week Range:
$10.21
$11.63
52-Week Range:
$3.35
$20.30
Contineum Therapeutics Inc Stock (CTNM) Company Profile
Name
Contineum Therapeutics Inc
Sector
Industry
Phone
(858) 333-5280
Address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO
Compare CTNM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTNM
Contineum Therapeutics Inc
|
11.50 | 308.18M | 0 | -35.46M | -34.00M | -0.4218 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Contineum Therapeutics Inc Stock (CTNM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-20-25 | Initiated | William Blair | Outperform |
| Oct-22-24 | Initiated | Robert W. Baird | Outperform |
| Apr-30-24 | Initiated | Morgan Stanley | Overweight |
| Apr-30-24 | Initiated | RBC Capital Mkts | Outperform |
| Apr-30-24 | Initiated | Stifel | Buy |
Contineum Therapeutics Inc Stock (CTNM) Latest News
Contineum Therapeutics Inc. Bounces Off Moving Average SupportBull Run & AI Powered Market Trend Analysis - beatles.ru
Key metrics from Contineum Therapeutics Inc.’s quarterly dataMarket Activity Report & Weekly Return Optimization Plans - Newser
Is Contineum Therapeutics Inc. stock ready for a breakout2025 Market Outlook & Capital Efficient Trade Techniques - Newser
Can volume confirm reversal in Contineum Therapeutics Inc.Portfolio Return Report & Weekly High Conviction Trade Ideas - Newser
What’s the beta of Contineum Therapeutics Inc. stockPortfolio Risk Summary & Low Risk High Reward Trade Ideas - خودرو بانک
What is the next catalyst for Contineum Therapeutics Inc.2025 Fundamental Recap & Stock Portfolio Risk Management - خودرو بانک
What’s the MACD signal for Contineum Therapeutics Inc.Sell Signal & Reliable Intraday Trade Alerts - خودرو بانک
Is Contineum Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
Is Contineum Therapeutics Inc. gaining market shareJuly 2025 Reactions & Reliable Momentum Entry Alerts - خودرو بانک
Tick level data insight on Contineum Therapeutics Inc. volatilityJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Can Contineum Therapeutics Inc. stock outperform in a bear marketGap Up & Risk Controlled Daily Trade Plans - خودرو بانک
Using data tools to time your Contineum Therapeutics Inc. exit2025 Top Gainers & Daily Chart Pattern Signal Reports - Newser
Long term hold vs stop loss in Contineum Therapeutics Inc.Earnings Growth Summary & Low Drawdown Investment Ideas - Newser
Analyzing Contineum Therapeutics Inc. with multi timeframe charts2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Charles Schwab Investment Management Inc. Has $357,000 Holdings in Contineum Therapeutics, Inc. $CTNM - Defense World
Does Contineum Therapeutics Inc. have pricing powerEarnings Miss & Technical Analysis for Trade Confirmation - خودرو بانک
Chart based exit strategy for Contineum Therapeutics Inc.Weekly Trade Analysis & Risk Controlled Daily Trade Plans - Newser
What indicators show strength in Contineum Therapeutics Inc.July 2025 Rallies & Intraday High Probability Alerts - Newser
Why is Contineum Therapeutics Inc. stock going down2025 Momentum Check & Fast Gaining Stock Reports - khodrobank.com
Is Contineum Therapeutics Inc. trending in predictive chart modelsTrade Risk Summary & Long-Term Capital Growth Ideas - Newser
Price momentum metrics for Contineum Therapeutics Inc. explainedEntry Point & Free Technical Confirmation Trade Alerts - Newser
Chart based analysis of Contineum Therapeutics Inc. trendsWeekly Market Summary & Long-Term Growth Stock Strategies - Newser
Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Rating of “Buy” from Analysts - Defense World
Can machine learning forecast Contineum Therapeutics Inc. recoveryJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
Real time breakdown of Contineum Therapeutics Inc. stock performanceWeekly Risk Summary & Proven Capital Preservation Tips - Newser
Contineum Therapeutics Inc. Bounces Off Moving Average Support getLinesFromResByArray error: size == 0 - sisaissue.com
News impact scoring models applied to Contineum Therapeutics Inc.Trade Volume Summary & Daily Chart Pattern Signals - Newser
How to build a dashboard for Contineum Therapeutics Inc. stock2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Will Contineum Therapeutics Inc. benefit from green energy policies2025 Earnings Impact & Low Drawdown Investment Ideas - خودرو بانک
Will Contineum Therapeutics Inc. benefit from seasonalityJuly 2025 Setups & Growth Oriented Trading Recommendations - خودرو بانک
How liquid is Contineum Therapeutics Inc. stockJuly 2025 Decliners & AI Powered Buy/Sell Recommendations - خودرو بانک
How institutional ownership impacts Contineum Therapeutics Inc. stockTrade Ideas & Daily Oversold Bounce Ideas - Newser
Published on: 2025-08-31 15:27:26 - Newser
What data driven models say about Contineum Therapeutics Inc.’s future2025 Price Targets & Low Risk Growth Stock Ideas - Newser
What machine learning models say about Contineum Therapeutics Inc.July 2025 Summary & Reliable Volume Spike Alerts - Newser
Contineum Therapeutics Inc Stock (CTNM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):